Harry B Greenberg
- Professor, Medicine - Gastroenterology & Hepatology
- Professor, Microbiology & Immunology
- Member, Bio-X
- Member, Cancer Center
Contact Information
- Clinical Offices
Gastroenterology 300 Pasteur Dr M121 MC 5187 Stanford, CA 94305 Telephone Work (650) 725-9722 Fax (650) 725-7368
- Academic Offices
Personal Information Email harry.greenberg@stanford.eduAdministrative Contact Shannon D. Shankle Administrative Associate in the Dean's Office Email sds@stanford.edu Tel Work 650-725-9722
Administrative Appointments
- Senior Associate Dean for Research, Stanford University School of Medicine , (2002– present )
Honors and Awards
- member, ASCI (1980)
- Member, AAP (1992)
- Fellow, AAAS (2003)
- Senior Editor, J Virology (2003-)
Professional Education
- BA, Dartmouth College History (1966)
- MD, Columbia College of P&S Medicine (1970)
- Board Cerification, Bellvue Hospital Internal Medicine (1973)
- Board Certification, Stanford Medical School Gastroenterology (1977)
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Consulting: Ligocyte, Medimmune Vaccines
- Equity: Aridis, DigitAB, Functional Genetics, Symphogen
Research Interests
Dr. Greenberg's current interests are in pathogenic viruses that infect the GI tract, liver and respiratory tract. His primary focus is on molecular mechanisms of pathogenesis, viral determinants of protective immunity, the molecular basis of host range, virulence and tissue tropism, vaccine development, viral immunology, and epidemiology with specific emphasis on the role of enteric viruses in less developed countries. Some of the ongoing studies in the lab deal with the following questions:
(i)What rotavirus gene(s) code for host range restriction, virulence and immunity? These studies involve the use of genetic analysis and studies of humoral and cellular immunity.
(ii)What proteins and what regions of the rotavirus proteins code for neutralizing epitopes, cell fusion activity, viral receptors, protective immunity? These studies involve sequence analysis, site-specific mutagenesis, and expression of viral genes.
(iii)What host cell genes are regulated by rotavirus replication in vitro and in vivo. These studies focus on microarray analysis and cell biology.
(iv)What are the immune effector mechanisms that mediate protection from and resolution of rotavirus infection? These studies involve animal models, cell transfer studies, FACS analysis and transgenic mice.
(v)What are the mechanisms by which class I restricted CD8 T cells modulate HCV infection. These studies involve analysis of peripheral and liver infiltrating human T cells using intracellular cytokine and tetramer techniques.
(vi)What is the basis of interferon effects on HCV? This analysis focuses on in vitro and in vivo microarray studies.
(Vii)What are the determinants of immunity to influenza following live and inactivated virus vaccination?
Clinical Trials
Publications
- Gastroenterology. 2009; (6): 1939-51
- J Virol. 2009; (21): 11372-7
- J Virol. 2009; (20): 10322-35
- J Virol. 2009; (14): 6987-94
- J Virol. 2008; (14): 6812-9
- J Infect Dis. 2008; (6): 803-11
- J Virol. 2008; (15): 7578-90
- Vaccine. 2008; (44): 5601-11
- PLoS One. 2008; (8): e2975
- PLoS One. 2008; (7): e2574
- Pediatr Infect Dis J. 2007; (2): 107-15
- Mol Biol Cell. 2007; (12): 4969-78
- Nat Rev Microbiol. 2007; (7): 529-39
- J Virol. 2007; (1): 215-28
- J Infect Dis. 2006; (5): 588-93
- Vaccine. 2006; (15): 2718-31
- J Virol. 2006; (13): 6702-5
- Vaccine. 2006; (31-32): 5817-23
- Virology. 2006; (1): 240-9
- J Virol. 2006; (8): 3935-46
- J Immunol. 2006; (10): 5749-59
- Hepatology. 2006; (2): 352-9
- J Virol. 2006; (11): 5219-32
- J Virol. 2006; (21): 10692-9
- J Infect Dis. 2006; (8): 1068-77
- J Virol. 2006; (23): 11756-66
- J Virol. 2005; (8): 4568-79
- Hepatology. 2005; (3): 517-25
- Hum Immunol. 2005; (6): 666-76
- J Virol. 2005; (17): 11014-21
- J Immunol. 2005; (6): 3454-60
- Methods Mol Med. 2004; 89-96
- J Med Virol. 2004; (4): 575-85
- J Immunol Methods. 2004; (1-2): 91-9
- J Infect Dis. 2004; (9): 1619-27
- J Infect Dis. 2004; (5): 989-97
- J Clin Invest. 2004; (12): 1812-9
- Pediatr Infect Dis J. 2004; (11 Suppl): S254-61
- J Infect Dis. 2004; (12): 2282-9
- J Virol. 2004; (20): 10967-76
- Mol Biol Cell. 2003; (7): 2959-71
- Hepatology. 2003; (3): 610-21
- J Hepatol. 2003; (1): 67-75
- Virology. 2003; (1): 93-105
- J Immunol Methods. 2003; (1-2): 223-37
- J Infect Dis. 2003; (7): 1075-84
- Virology. 2003; (2): 671-9
- J Immunol. 2003; (9): 4680-8
- Virology. 2003; (1): 308-21
- J Virol. 2003; (10): 6055-61
- J Virol. 2002; (10): 4741-9
- Control Clin Trials. 2002; (3): 222-39
- J Clin Invest. 2002; (9): 1203-13
- Viral Immunol. 2002; (1): 121-31
- J Virol. 2002; (9): 4467-82
- J Immunol. 2002; (5): 2173-81
- J Exp Med. 2002; (2): 269-75
- Am J Pathol. 2002; (1): 347-55
- J Virol. 2002; (20): 10465-72
- Proc Natl Acad Sci U S A. 2002; (17): 11411-6
- J Immunol. 2002; (6): 3447-58
- Immunology. 2002; (4): 420-5
- J Clin Invest. 2001; (5): 595-601
- Virology. 2001; (2): 153-5
- Vaccine. 2001; (23-24): 3285-91
- J Virol. 2001; (16): 7339-50
- J Mol Biol. 2001; (5): 985-92
- J Immunol. 2001; (2): 877-84
- J Immunol.. 2001; (166): 1894-192
- J Infect Dis. 2001; (7): 827-35
- Arch Virol. 2001; (6): 1155-71
- Viral Immunol. 2001; (1): 59-69
- J Immunol. 2001; (3): 1894-902
- J Immunol. 2001;
- J Clin Invest. 2000; (12): 1541-52
- J Exp Med. 2000; (5): 761-8
- J Infect Dis. 2000; S331-5
- Nat Med. 2000; (3): 327-31
- Curr Opin Microbiol. 2000; (4): 363-5
- Hepatology. 2000; (2): 433-5
- Immunity. 2000; (5): 495-503
- J Virol. 2000; (11): 5250-6
- Virology. 2000; (2): 420-8
- Virology. 2000; (2): 444-53
- Trends Microbiol. 2000; (2): 50-2
- J Interferon Cytokine Res. 1999; (6): 655-9
- Proc Natl Acad Sci U S A. 1999; (10): 5692-7
- Gastroenterology. 1999; (6): 1397-407
- J Infect Dis. 1999; S466-9
- Virology. 1999; (1): 148-53
- Vaccine. 1999; (23-24): 3171-6
- J Immunol. 1999; (8): 4442-52
- J Clin Microbiol. 1999; (4): 1213-6
- J Virol. 1998; (1): 726-30
- J Infect Dis. 1998; (2): 455-8
- J Gen Virol. 1998; 725-9
- J Virol. 1998; (7): 5757-61
- J Clin Microbiol. 1998; (11): 3223-9
- J Clin Microbiol. 1998; (6): 1688-92
- Arch Virol. 1998; (2): 263-77
- J Virol. 1998; (6): 5323-7
- J Virol. 1998; (11): 9303-6
- J Immunol. 1998; (8): 4227-35
- Adv Virus Res. 1998; 203-35
- J Virol. 1997; (1): 479-86
- Virology. 1997; (1): 89-96
- Am J Gastroenterol. 1997; (11): 1986-91
- Vaccine. 1997; (8): 899-902
- Virology. 1997; (2): 169-79
- J Clin Invest. 1997; (5): 1204-8
- J Infect Dis. 1997; (2): 330-41
- J Virol. 1997; (5): 4165-70
- J Virol. 1997; (6): 4555-63
- J Infect Dis. 1997; (6): 1317-23
- West J Med. 1997; (1): 23-33
- Adv Exp Med Biol. 1997; 233-40
- J Virol. 1996; (1): 487-93
- Arch Virol Suppl. 1996; 141-52
- Science. 1996; (5258): 104-7
- J Clin Microbiol. 1996; (7): 1694-700
- J Infect Dis. 1996; S47-50
- J Clin Microbiol. 1996; (10): 2552-8
- J Gen Virol. 1996; 391-5
- Arch Virol. 1996; (3-4): 715-26
- Arch Virol Suppl. 1996; 207-15
- J Infect Dis. 1996; S93-7
- Virology. 1996; (1): 97-110
- J Virol. 1995; (3): 1747-54
- Virology. 1995; (1): 143-53
- J Virol. 1995; (9): 5582-91
- Clin Diagn Lab Immunol. 1995; (4): 506-8
- J Gen Virol. 1995; 1981-8
- Virology. 1995; (1): 148-54
- J Virol. 1995; (12): 7800-6
- Arch Virol. 1995; (11): 1969-78
- J Virol. 1994; (12): 7766-73
- Virology. 1994; (1): 391-402
- Virology. 1994; (2): 250-9
- Virology. 1994; (1): 178-83
- J Virol. 1994; (8): 5204-15
- J Virol. 1994; (1): 77-83
- Curr Top Microbiol Immunol. 1994; 255-83
- J Virol. 1994; (10): 6147-60
- J Clin Microbiol. 1994; (10): 2593-7
- Virology. 1994; (1): 153-62
- Am J Gastroenterol. 1994; (8): 1169-74
- Isr J Med Sci. 1994; (3): 240-2
- Hepatology. 1993; (5): 763-71
- Virology. 1993; (1): 397-404
- J Neurocytol. 1993; (8): 616-26
- Ann N Y Acad Sci. 1993; 32-5
- Virology. 1993; (1): 374-9
- J Virol. 1993; (5): 2448-55
- J Clin Microbiol. 1993; (4): 955-62
- J Virol. 1993; (1): 464-8
- J Clin Microbiol. 1993; (3): 622-8
- J Virol. 1993; (3): 1712-5
- J Clin Microbiol. 1993; (1): 165-9
- J Clin Microbiol. 1992; (12): 3151-7
- Virology. 1992; (1): 18-32
- J Virol. 1992; (11): 6836-9
- J Clin Microbiol. 1992; (3): 704-11
- Arch Virol. 1992; (1-4): 239-51
- J Clin Microbiol. 1992; (6): 1392-7
- J Clin Invest. 1992; (6): 1741-5
- Infect Agents Dis. 1992; (2): 71-91
- J Clin Invest. 1992; (6): 2313-20
- Virology. 1992; (2): 828-32
- J Clin Invest. 1992; (1): 3-9
- Virology. 1991; (2): 553-63
- J Clin Invest. 1991; (4): 1456-61
- J Virol. 1991; (5): 2211-9
- J Virol. 1991; (8): 4190-7
- Virology. 1991; (2): 602-10
- N Engl J Med. 1991; (4): 252-64
- Gastroenterology. 1991; (6): 1724-7
- J Virol. 1991; (11): 5928-32
- Hepatology. 1991; (5): 763-7
- J Infect Dis. 1990; (1): 18-21
- J Clin Microbiol. 1990; (3): 504-7
- Am J Epidemiol. 1990; (4): 702-10
- Am J Vet Res. 1990; (6): 938-44
- J Virol. 1990; (6): 2687-91
- J Cell Biol. 1990; (6): 2133-44
- J Infect Dis. 1990; (3): 605-14
- J Virol. 1990; (1): 411-3
- J Virol. 1990; (1): 120-4
- J Virol. 1990; (1): 322-30
- Proc Natl Acad Sci U S A. 1990; (2): 518-22
- J Virol. 1990; (1): 361-8
- Virology. 1990; (2): 546-52
- J Clin Microbiol. 1990; (6): 1114-9
- J Virol. 1990; (9): 4375-82
- J Virol. 1990; (4): 1698-703
- Virology. 1989; (2): 503-15
- J Virol. 1989; (8): 3279-83
- Nucleic Acids Res. 1989; (1): 449
- J Clin Microbiol. 1989; (4): 780-2
- Adv Virus Res. 1989; 181-214
- Gastroenterology. 1989; (4): 1031-2
- J Virol. 1989; (6): 2445-51
- J Virol. 1989; (4): 1661-8
- Proc Natl Acad Sci U S A. 1988; (3): 645-9
- J Virol. 1988; (4): 1136-44
- Virology. 1988; (2): 511-7
- J Virol. 1988; (9): 3509-12
- Pediatr Infect Dis J. 1988; (11): 776-80
- J Virol. 1988; (5): 1543-9
- J Virol. 1988; (6): 2164-72
- J Clin Microbiol. 1988; (6): 1238-40
- J Virol. 1988; (8): 2929-41
- J Clin Microbiol. 1988; (10): 2139-43
- J Virol. 1988; (11): 4358-61
- J Infect Dis. 1987; (6): 1159-66
- Gastroenterology. 1987; (5): 941-50
- J Virol. 1986; (2): 585-90
- J Virol. 1986; (2): 700-3
- Am J Epidemiol. 1986; (1): 120-6
- J Virol. 1986; (2): 491-6
- Virology. 1986; (2): 434-51
- J Virol. 1986; (1): 46-9
- J Clin Microbiol. 1985; (2): 286-91
- J Virol. 1985; (3): 949-54
- J Infect Dis. 1985; (1): 99-105
- J Infect Dis. 1984; (4): 531-4
- Virus Res. 1984; (2): 133-52
- Ann Intern Med. 1984; (4): 519-21
- J Infect Dis. 1984; (5): 694-702
- Infect Immun. 1983; (1): 169-73
- J Gen Virol. 1983; 313-20
- Virology. 1983; (1): 194-205
- Prog Food Nutr Sci. 1983; (3-4): 189-92
- Dev Biol Stand. 1983; 209-18
- J Clin Microbiol. 1983; (2): 310-7
- J Virol. 1983; (2): 267-75
- Infect Immun. 1983; (3): 1031-7
- J Clin Microbiol. 1983; (3): 585-91
- J Infect Dis. 1983; (1): 95-106
- Arch Environ Health. 1982 Nov-Dec; (6): 358-60
- Hepatology. 1982 Jan-Feb; (1): 39-49
- J Virol. 1982; (3): 1032-7
- Virology. 1982; (2): 288-95
- Infect Immun. 1982; (1): 110-5
- Ann Intern Med. 1982; (6 Pt 1): 756-61
- J Infect Dis. 1982; (4): 483-9
- Am J Epidemiol. 1982; (3): 348-51
- Am J Epidemiol. 1982; (2): 173-7
- Am J Epidemiol. 1982; (2): 163-72
- Am J Public Health. 1982; (1): 72-4
- Am J Epidemiol. 1982; (5): 834-9
- Gastroenterology. 1982; (6): 1207-9
- Infect Immun. 1982; (1): 104-9
- Hepatology. 1981 May-Jun; (3): 228-32
- Hepatology. 1981 Jan-Feb; (1): 54-7
- Virology. 1981; (2): 385-90
- Proc Natl Acad Sci U S A. 1981; (1): 420-4
- Aust J Exp Biol Med Sci. 1981; (Pt 2): 219-28
- J Virol. 1981; (3): 994-9
- Infect Immun. 1981; (2): 415-25
- Infect Immun. 1981; (3): 958-61
- Am Rev Respir Dis. 1981; (3): 341
- Am J Epidemiol. 1981; (4): 584-92
- Rev Infect Dis. 1980 May-Jun; (3): 459-69
- J La State Med Soc. 1980; (2): 17-8
- Science. 1980; (4427): 189-91
- J Med Virol. 1980; (1): 11-9
- Am J Trop Med Hyg. 1980; (2): 298-312
- Gastroenterology. 1980; (6): 1495-9
- Infect Immun. 1980; (1): 108-13
- Am J Epidemiol. 1980; (6): 820-7
- J Clin Microbiol. 1979; (6): 903-9
- Infect Immun. 1979; (1): 270-3
- Lancet. 1979; (8140): 466-7
- Gastroenterology. 1979; (6): 1368-73
- J Infect Dis. 1979; (5): 564-8
- J Clin Microbiol. 1979; (1): 60-4
- Am J Trop Med Hyg. 1979; (2): 325-8
- Hosp Infect Control. 1979; (3): 29-30
- Gastroenterology. 1979; (2): 349-50
- Lancet. 1979; (8106): 55
- J Clin Microbiol. 1979; (4): 488-92
- N Engl J Med. 1978; (21): 1156-61
- J Med Virol. 1978; (2): 89-96
- J Med Virol. 1978; (2): 97-108
- J Med Virol. 1978; (4): 281-94
- Am J Hematol. 1978; (3): 247-52
- J Am Vet Med Assoc. 1978; (5 Pt 2): 620-3
- J Clin Microbiol. 1977; (5): 439-44
- J Virol. 1977; (2): 368-76
- Infect Immun. 1977; (3): 541-5
- N Engl J Med. 1976; (10): 517-22
- Infect Immun. 1973; (4): 612-20
- J Infect Dis. 1971; (4): 356-64
- JAMA. 1970; (5): 877-9
- Lancet. 1969; (7614): 248-9